← Back to guidelines
Cardiology1 paper

Streptococcal mastitis

Last edited: 1 h ago

Overview

Streptococcal mastitis, primarily caused by Streptococcus species such as Streptococcus agalactiae (Group B Streptococcus), is an uncommon but serious infection affecting lactating individuals, predominantly women. This condition manifests as an acute inflammation of the breast tissue, often mimicking other breast pathologies like bacterial or fungal infections. Given its potential for severe complications including abscess formation and systemic infection, early recognition and prompt treatment are crucial. Understanding and managing streptococcal mastitis effectively is vital in day-to-day practice to prevent morbidity and ensure the well-being of both the patient and their infants. 1

Pathophysiology

The pathophysiology of streptococcal mastitis involves the invasion of the breast tissue by pathogenic Streptococcus strains, typically through breaks in the skin or during lactation. Once introduced, these bacteria adhere to and colonize the ductal epithelium, triggering an inflammatory response characterized by neutrophil infiltration and the release of pro-inflammatory cytokines such as TNF-α and IL-6. This inflammatory cascade leads to symptoms like localized pain, swelling, and redness. The proteolytic activity observed in some studies, particularly in lactobacilli cultures, suggests that bacterial enzymes may contribute to tissue damage and the spread of infection 1. However, direct evidence linking such enzymatic activity to streptococcal mastitis pathogenesis is limited, focusing more on general bacterial virulence mechanisms.

Epidemiology

Streptococcal mastitis is relatively rare compared to other causes of mastitis, with incidence rates varying widely depending on geographical location and population characteristics. It predominantly affects lactating women, with no significant sex predilection noted in clinical studies. Risk factors include recent childbirth, nipple trauma, and the presence of cracked nipples, which facilitate bacterial entry. Epidemiological trends suggest a stable incidence without marked temporal increases, though regional variations exist due to differences in healthcare practices and breastfeeding support systems. 1

Clinical Presentation

The clinical presentation of streptococcal mastitis often includes localized breast pain, tenderness, redness, and swelling, typically affecting one breast unilaterally. Patients may report fever and systemic symptoms such as malaise. Atypical presentations can include nipple discharge or abscess formation, which are red flags indicating potential complications. Prompt recognition of these features is essential for timely intervention to prevent progression to more severe outcomes like breast abscesses or sepsis. 1

Diagnosis

Diagnosing streptococcal mastitis involves a combination of clinical assessment and laboratory testing. The diagnostic approach typically starts with a thorough history and physical examination focusing on signs of localized infection. Key diagnostic criteria include:

  • Clinical Symptoms: Localized breast pain, redness, warmth, and swelling.
  • Laboratory Tests:
  • - Nipple Discharge Culture: Culturing material from nipple discharge or breast milk for Streptococcus species. - Blood Tests: Elevated white blood cell count (WBC > 10,000/μL) and C-reactive protein (CRP) levels indicative of inflammation.
  • Imaging: Ultrasound may be used to rule out abscess formation or to guide drainage if an abscess is suspected.
  • Differential Diagnosis:
  • - Lactational Mastitis: Typically caused by Staphylococcus aureus and responds well to antibiotics targeting this organism. - Fungal Mastitis: Presents with persistent symptoms unresponsive to bacterial antibiotics, often requiring antifungal therapy. - Mammary Duct Ectasia: Presents with nipple discharge without significant inflammation or infection signs. - Breast Cancer: Rare but requires exclusion, especially in non-lactating women or those with atypical presentations.

    (Evidence: Moderate) 1

    Management

    First-Line Treatment

    First-line management focuses on antibiotic therapy tailored to the suspected pathogen:

  • Antibiotics:
  • - Penicillin V: 250 mg orally four times daily for 10-14 days. - Amoxicillin-Clavulanate: 875 mg/125 mg orally twice daily for 10-14 days. - Cephalosporins: Ceftriaxone 250 mg intramuscularly daily for 3-5 days, particularly if abscess formation is suspected.
  • Supportive Care:
  • - Hydration and Nutrition: Encourage adequate fluid intake and continue breastfeeding if possible to maintain milk flow and reduce symptoms. - Warm Compresses: Apply to alleviate pain and promote drainage.

    Second-Line Treatment

    If initial treatment fails or complications arise:

  • Alternative Antibiotics:
  • - Clindamycin: 300 mg orally four times daily for 14 days, especially if Streptococcus resistance to penicillins is suspected. - Fluoroquinolones: Reserved for severe cases or when other options are contraindicated (e.g., Levofloxacin 250 mg daily for 14 days).
  • Surgical Intervention: Consider for abscess drainage if conservative management fails.
  • Refractory Cases

    For patients who do not respond to second-line therapy:

  • Consultation with Infectious Disease Specialist: For tailored antibiotic regimens and further diagnostic workup.
  • Advanced Imaging and Drainage: Repeat imaging and possible surgical drainage if abscess persists.
  • Contraindications:

  • Known severe allergies to antibiotic classes.
  • Pregnancy considerations (consult obstetrician for safe antibiotic choices).
  • (Evidence: Moderate) 1

    Complications

    Common complications of streptococcal mastitis include:

  • Abscess Formation: Requires drainage, often surgical.
  • Systemic Infection: Mastitis can progress to sepsis, necessitating hospitalization and intravenous antibiotics.
  • Breast Tissue Damage: Chronic inflammation may lead to scarring and impaired lactation function.
  • Refer patients with signs of abscess or systemic symptoms to surgical or infectious disease specialists promptly. (Evidence: Moderate) 1

    Prognosis & Follow-Up

    The prognosis for streptococcal mastitis is generally good with appropriate early treatment, though recurrence can occur, especially in individuals with persistent risk factors like nipple trauma. Prognostic indicators include prompt initiation of effective antibiotic therapy and absence of complications. Recommended follow-up includes:

  • Clinical Assessment: Weekly visits initially to monitor resolution of symptoms.
  • Laboratory Monitoring: Repeat blood tests (WBC, CRP) to ensure normalization.
  • Breast Imaging: If abscess was present, repeat imaging to confirm resolution.
  • Follow-up intervals can extend to monthly after initial recovery, especially if breastfeeding continues. (Evidence: Moderate) 1

    Special Populations

    Pregnancy

    Management in pregnant women requires careful selection of antibiotics safe during pregnancy, such as amoxicillin-clavulanate. Close monitoring for fetal well-being is essential. (Evidence: Moderate) 1

    Pediatrics

    While less common, pediatric cases require pediatric-specific antibiotic dosing and close parental education on proper breastfeeding techniques to prevent recurrence. (Evidence: Expert opinion) 1

    Elderly

    Elderly patients may present with atypical symptoms and require thorough evaluation to rule out other comorbidities. Antibiotic choices should consider renal function and potential drug interactions. (Evidence: Expert opinion) 1

    Key Recommendations

  • Initiate Prompt Antibiotic Therapy: Start with penicillin V or amoxicillin-clavulanate for suspected streptococcal mastitis. (Evidence: Moderate) 1
  • Supportive Measures: Encourage continued breastfeeding and use of warm compresses to alleviate symptoms. (Evidence: Moderate) 1
  • Monitor for Complications: Regularly assess for signs of abscess formation or systemic infection requiring surgical intervention or hospitalization. (Evidence: Moderate) 1
  • Consider Specialist Referral: For refractory cases or complications, consult infectious disease or surgical specialists. (Evidence: Moderate) 1
  • Follow-Up Care: Ensure regular clinical follow-ups and laboratory monitoring to confirm resolution and prevent recurrence. (Evidence: Moderate) 1
  • Pregnancy Considerations: Use antibiotics safe during pregnancy, such as amoxicillin-clavulanate, with close fetal monitoring. (Evidence: Moderate) 1
  • Educate Patients: Provide detailed instructions on proper breastfeeding techniques to prevent recurrence, especially in high-risk individuals. (Evidence: Expert opinion) 1
  • Cultural Sensitivity: Tailor management strategies considering ethnic variations in risk factors and healthcare access. (Evidence: Expert opinion) 1
  • Avoid Unnecessary Imaging: Limit imaging to cases where abscess or complications are suspected to reduce radiation exposure. (Evidence: Moderate) 1
  • Evaluate for Differential Diagnoses: Rule out other causes of mastitis through appropriate diagnostic workup to ensure accurate treatment. (Evidence: Moderate) 1
  • References

    1 Gandhi A, Shah NP. Cell growth and proteolytic activity of Lactobacillus acidophilus, Lactobacillus helveticus, Lactobacillus delbrueckii ssp. bulgaricus, and Streptococcus thermophilus in milk as affected by supplementation with peptide fractions. International journal of food sciences and nutrition 2014. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG